Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Furtak, Vyacheslav ^a   Mulky, Alok ^b   Rawlings, Stephen A ^a   Kozhaya, Lina ^a   Lee, KyeongEun ^b   KewalRamani, Vineet N ^b   Unutmaz, Derya ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; PROTEIN MOV10; RNA HELICASE; UNCLASSIFIED DRUG; GAG PROTEIN; GREEN FLUORESCENT PROTEIN; MOV10 PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CD4+ T LYMPHOCYTE; CELL ORGANELLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; P BODY; PROTEIN EXPRESSION; VIRUS INFECTIVITY; VIRUS REPLICATION; CELL CULTURE; CELL LINE; CYTOLOGY; ENZYME ACTIVE SITE; GENETIC TRANSFECTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HELA CELL; LEUKEMIA CELL LINE; METABOLISM; MUTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL LINE; VIRION; VIROLOGY; WESTERN BLOTTING;

GAMMARETROVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINE LEUKEMIA VIRUS;

BLOTTING, WESTERN; CATALYTIC DOMAIN; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; GREEN FLUORESCENT PROTEINS; HELA CELLS; HIV CORE PROTEIN P24; HIV-1; HUMANS; JURKAT CELLS; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA HELICASES; RNA INTERFERENCE; TRANSFECTION; VIRION; VIRUS REPLICATION;

EID: 77949408184     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009081     Document Type: Article

References (33)

1. Bushman FD, Malani N, Fernandes J, D'Orso I, Cagney G, et al. (2009) Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog 5: e1000437.
2. Bieniasz PD (2009) The cell biology of HIV-1 virion genesis. Cell Host Microbe 5: 550-558.
3. Strebel K, Luban J, Jeang KT (2009) Human cellular restriction factors that target HIV-1 replication. BMC Med 7: 48.
4. Cullen BR (2006) Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors. J Virol 80: 1067-1076.
5. Sheehy AM, Gaddis NC, Choi JD, Malim MH (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418: 646-650.
6. Gallois-Montbrun S, Kramer B, Swanson CM, Byers H, Lynham S, et al. (2007) Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules. J Virol 81: 2165-2178.
7. Beckham CJ, Parker R (2008) P bodies, stress granules, and viral life cycles. Cell Host Microbe 3: 206-212.
8. Eulalio A, Behm-Ansmant I, Izaurralde E (2007) P bodies: at the crossroads of post-transcriptional pathways. Nat Rev Mol Cell Biol 8: 9-22.
9. Kozak SL, Marin M, Rose KM, Bystrom C, Kabat D (2006) The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules. J Biol Chem 281: 29105-29119.
10. Schnieke A, Stuhlmann H, Harbers K, Chumakov I, Jaenisch R (1983) Endogenous Moloney leukemia virus in nonviremic Mov substrains of mice carries defects in the proviral genome. J Virol 45: 505-513.
11. Dalmay T, Horsefield R, Braunstein TH, Baulcombe DC (2001) SDE3 encodes an RNA helicase required for post-transcriptional gene silencing in Arabidopsis. Embo J 20: 2069-2078.
12. Haussecker D, Cao D, Huang Y, Parameswaran P, Fire AZ, et al. (2008) Capped small RNAs and MOV10 in human hepatitis delta virus replication. Nat Struct Mol Biol 15: 714-721.
13. Ma J, Rong L, Zhou Y, Roy BB, Lu J, et al. (2008) The requirement of the DEAD-box protein DDX24 for the packaging of human immunodeficiency virus type 1 RNA. Virology 375: 253-264.
14. Zhou Y, Ma J, Bushan Roy B, Wu JY, Pan Q, et al. (2008) The packaging of human immunodeficiency virus type 1 RNA is restricted by overexpression of an RNA helicase DHX30. Virology 372: 97-106.
15. Cordin O, Banroques J, Tanner NK, Linder P (2006) The DEAD-box protein family of RNA helicases. Gene 367: 17-37.
16. de la Cruz J, Kressler D, Linder P (1999) Unwinding RNA in Saccharomyces cerevisiae: DEAD-box proteins and related families. Trends Biochem Sci 24: 192-198.
17. Askjaer P, Rosendahl R, Kjems J (2000) Nuclear export of the DEAD box An3 protein by CRM1 is coupled to An3 helicase activity. J Biol Chem 275: 11561-11568.
18. Chendrimada TP, Finn KJ, Ji X, Baillat D, Gregory RI, et al. (2007) MicroRNA silencing through RISC recruitment of eIF6. Nature 447: 823-828.
19. Baillat D, Shiekhattar R (2009) Functional dissection of the human TNRC6 (GW182-related) family of proteins. Mol Cell Biol 29: 4144-4155.
20. Meister G, Landthaler M, Peters L, Chen PY, Urlaub H, et al. (2005) Identification of novel argonaute-associated proteins. Curr Biol 15: 2149-2155.
21. Niewiadomska AM, Tian C, Tan L, Wang T, Sarkis PT, et al. (2007) Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association. J Virol 81: 9577-9583.
22. Checkley MA, Nagashima K, Lockett SJ, Nyswaner KM, Garfinkel DJ P-Body Components Are Required for Ty1 Retrotransposition during Assembly of Retrotransposition-Competent Virus-Like Particles. Mol Cell Biol 30: 382-398.
23. Beliakova-Bethell N, Beckham C, Giddings TH Jr, Winey M, Parker R, et al. (2006) Virus-like particles of the Ty3 retrotransposon assemble in association with P-body components. Rna 12: 94-101.
24. Ott DE (2008) Cellular proteins detected in HIV-1. Rev Med Virol 18: 159-175.
25. Gibbings DJ, Ciaudo C, Erhardt M, Voinnet O (2009) Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol 11: 1143-1149.
26. Goila-Gaur R, Demirov DG, Orenstein JM, Ono A, Freed EO (2003) Defects in human immunodeficiency virus budding and endosomal sorting induced by TSG101 overexpression. J Virol 77: 6507-6519.
27. Southey R (1837) The Story of The Three Bears.
28. Unutmaz D, KewalRamani VN, Marmon S, Littman DR (1999) Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J Exp Med 189: 1735-1746.
29. Nguyen KL, llano M, Akari H, Miyagi E, Poeschla EM, et al. (2004) Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression. Virology 319: 163-175.
30. Oswald-Richter K, Grill SM, Leelawong M, Tseng M, Kalams SA, et al. (2007) Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection. PLoS Pathog 3: e58.
31. Bartz SR, Vodicka MA (1997) Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein. Methods 12: 337-342.
32. Pear WS, Miller JP, Xu L, Pui JC, Soffer B, et al. (1998) Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood 92: 3780-3792.
33. Julias JG, Ferris AL, Boyer PL, Hughes SH (2001) Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase. J Virol 75: 6537-6546.